Sera Prognostics Joins $10.4M ARPA-H Research Program
Sera Prognostics (SERA) announced its participation in a multi-institutional research program that was awarded up to $10.4M by the Advanced Research Projects Agency for Health, or ARPA-H, to develop a novel point-of-care diagnostic test designed to improve the safety of labor and delivery. The award, part of ARPA-H's Making Obstetrics Care Smart program, supports a collaboration led by researchers at the University of California San Diego alongside Sera Prognostics and Allegro MicroSystems (ALGM). The program aims to develop new technologies that enable more precise, data-driven decision-making during childbirth. The research team is working to develop a diagnostic approach that can assess the risk of low fetal oxygen levels from a small maternal blood sample. The program will explore the integration of identified biomarkers into a rapid, point-of-care testing platform capable of delivering results from a small maternal blood sample.
